Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir/Ritonavir/Efavirenz Nucleoside Sparing Regimen
NCT00135343Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Apr 2004; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00135343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135343.